Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, 9019 Tromsø, Norway.
Division of Internal Medicine, University Hospital of North Norway, 9019 Tromsø, Norway.
J Clin Endocrinol Metab. 2017 Oct 1;102(10):3731-3738. doi: 10.1210/jc.2017-01187.
Vitamin D and 25-hydroxyvitamin D [25(OH)D] are stored in adipose tissue, but the clinical relevance is uncertain.
To evaluate changes in serum 25(OH)D and adipose tissue vitamin D levels after stopping vitamin D supplementation.
A prospective, double-blind cohort follow-up study.
Clinical Research Unit at University Hospital of North Norway.
Seventy-six subjects were included after participation in a 3- to 5-year prevention of type 2 diabetes study and were administered 20,000 IU of vitamin D or placebo per week.
During the 12-month follow-up period, blood samples were drawn at the beginning and after 1, 3, 6, 9, and 12 months. Fat biopsies were taken at the start and end.
Changes in 25(OH)D level in serum and 25(OH)D and vitamin D levels in adipose tissue.
Forty-one of 42 subjects who were given vitamin D and 33 of 34 subjects who were given placebo completed the study. At the inclusion, mean serum 25(OH)D levels were 122 and 71 nmol/L in the vitamin D and placebo groups, respectively. Serum 25(OH)D levels were significantly higher in the vitamin D group than in the placebo group throughout and were 84.5 and 73.1 nmol/L, respectively, after 12 months. In the vitamin D group, adipose tissue vitamin D levels decreased by 52% over 12 months.
Vitamin D and 25(OH)D stored in adipose tissue after 3 to 5 years of vitamin D supplementation may have a clinically relevant effect on serum 25(OH)D level the following year.
维生素 D 和 25-羟维生素 D[25(OH)D]储存在脂肪组织中,但临床相关性尚不确定。
评估停止维生素 D 补充后血清 25(OH)D 和脂肪组织维生素 D 水平的变化。
前瞻性、双盲队列随访研究。
挪威北大学医院临床研究单位。
76 例患者参加了一项为期 3 至 5 年的 2 型糖尿病预防研究,每周接受 20,000IU 维生素 D 或安慰剂治疗。
在 12 个月的随访期间,在开始时和 1、3、6、9 和 12 个月时抽取血样。在开始和结束时采集脂肪活检。
血清 25(OH)D 水平变化及脂肪组织 25(OH)D 和维生素 D 水平变化。
42 名给予维生素 D 的患者中有 41 名和 34 名给予安慰剂的患者中有 33 名完成了研究。纳入时,维生素 D 组和安慰剂组的血清 25(OH)D 水平分别为 122 和 71nmol/L。在整个研究过程中,维生素 D 组的血清 25(OH)D 水平均显著高于安慰剂组,12 个月后分别为 84.5 和 73.1nmol/L。在维生素 D 组,脂肪组织维生素 D 水平在 12 个月内下降了 52%。
在接受 3 至 5 年维生素 D 补充后,脂肪组织中储存的维生素 D 和 25(OH)D 可能对次年血清 25(OH)D 水平产生临床相关影响。